share_log

Critical Insights From Merck & Co Analyst Ratings: What You Need To Know

Critical Insights From Merck & Co Analyst Ratings: What You Need To Know

来自默沙东分析师评级的关键见解:你需要知道的
Benzinga ·  02/29 14:01
In the preceding three months, 10 analysts have released ratings for Merck & Co (NYSE:MRK), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中,10位分析师发布了默沙东公司(纽约证券交易所代码:MRK)的评级,提出了从看涨到看跌的各种观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您将找到他们最近的评级摘要,揭示了过去30天中情绪的变化,并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $137.2, with a high estimate of $148.00 and a low estimate of $130.00. This upward trend is apparent, with the current average reflecting a 6.63% increase from the previous average price target of $128.67.
分析师对12个月目标股价的评估提供了更多见解,显示平均目标价为137.2美元,最高估计为148.00美元,低估值为130.00美元。这种上升趋势显而易见,当前的平均价格较之前的平均目标价128.67美元上涨了6.63%。
Diving into Analyst Ratings...
深入分析...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发